PGx testing can offer insightful information about how a person may react to a variety of medications, such as cardiovascular treatments, painkillers, antidepressants, and more. PGx testing has the potential to enhance patient outcomes, reduce adverse drug responses, and improve overall medication management by optimizing medicine selection and dose based on genetic characteristics.
However, it is crucial to emphasize that PGx testing is not yet commonly used in clinical practice, and its utility may vary depending on the drugs and genetic variations under investigation. Furthermore, ethical constraints, privacy problems, and the need for additional research to prove its clinical efficacy are all significant factors to consider when implementing PGx testing broadly.